AstraZeneca (NASDAQ: AZN) has overhauled its local management in China, replacing Michael Lai with Alex Lin as the country’s general […]
AstraZeneca Overhauls Management of Its China Division, FT Reports Read More »
SHANGHAI – AstraZeneca’s (NASDAQ: AZN) blockbuster breast cancer drug Enhertu will be added to China’s state-run health insurance scheme from
China Adds AstraZeneca’s Breast Cancer Drug Enhertu to State Health Coverage Read More »
LONDON – AstraZeneca’s (NASDAQ: AZN) China president Leon Wang, who was detained last month by Chinese authorities, is in touch
AstraZeneca CEO Offers Update on Leon Wang’s Detention, But Details Remain Limited Read More »
LONDON – On Wednesday, AstraZeneca (NASDAQ: AZN) said its China president Leon Wang had been detained by Chinese authorities and,
AstraZeneca’s China Chief in Custody, Believes Arrest Unrelated to Insurance Probe Read More »
AstraZeneca’s (NASDAQ: AZN) China president is under investigation and is cooperating with Chinese authorities, the company said on Wednesday, sending
AstraZeneca (NASDAQ: AZN) Stock Falls on News of China President’s Investigation Read More »
On Monday, AstraZeneca (NASDAQ: AZN) said it would pay up to $1.92 billion to CSPC Pharmaceutical Group Ltd in an
AstraZeneca (NASDAQ: AZN) shares fell in the pre-market trading Tuesday after results from the company’s lung cancer trials showed that
AstraZeneca (NASDAQ: AZN) Stock Dips on Lung Cancer Drug Trial Setback Read More »
LONDON – Detailed results from one of AstraZeneca’s (NASDAQ: AZN) key lung cancer trials released on Monday showed that its
Police in China have detained five current and former employees of AstraZeneca (NASDAQ: AZN) for questioning about potential illegal activities,
China Detains AstraZeneca (NASDAQ: AZN) Employees in Data, Drug-Import Probes: Bloomberg Read More »
Copyright © 2025 abbonews.com
